FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc., in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug giant is practically paying people to keep taking it after generic rivals hit the U.S. market this week. Some patients won't even have the option to switch to the generic. (AP Photo/Matt Rourke, File)
Message Sent Successfully
Be Sure to Check Out Our Top Headlines
Back to share with a friend form.
Add More Recipients
Send me a copy of this email.